HOME >> BIOLOGY >> NEWS
Monsanto to share technologies with Danforth Center to support global cassava research

ted Nations Human Development Report 2001 also encouraged greater public investment in research and development to ensure that biotechnology is used to meet the agricultural needs of the world's poor.

"By sharing our technology and other scientific knowledge, Monsanto hopes to encourage other companies and technology developers to do the same, said Robb Fraley, Chief Technology Officer of Monsanto.

Working together in public and private sector partnerships promotes a wide variety of discoveries to enhance food security and nutrition throughout the developing world. We look forward to continuing our support of the cassava research program as it develops, said Fraley.

Monsanto also is supporting the Danforth Centers efforts to develop virus-resistant cassava through a multi-year grant from the companys philanthropic organization, the Monsanto Fund. Monsantos contributions to the Danforth Center are in keeping with the New Monsanto Pledge and its commitment to sharing knowledge and technology with public institutions to benefit people and the environment, particularly in the developing world.

In August 2000, Monsanto granted similar royalty-free licenses to the inventors of golden rice, which is being developed to combat vitamin A deficiency in developing countries. Other sharing projects include providing access to a working draft of the rice genome and participating in work to develop virus-resistant sweet potatoes in Africa and papayas in South East Asia.


'"/>

Contact: Shannon Troughton
314-694-2320
Monsanto Company
16-Apr-2002


Page: 1 2

Related biology news :

1. Washington University in St. Louis, Monsanto Co., awarded crop protection patent
2. Monsanto and researchers celebrate first anniversary of sharing rice genome sequence data
3. Monsanto adds support for golden rice; opens its rice genome sequence data to worldwide research community
4. Monsantos modified soya beans dont agree with the heat
5. Bone, enamel, dentine, milk & saliva share gene family
6. K-State researchers share $1 million grant to study insect pests
7. Cross-species comparison reveals shared features between tumorigenesis and organogenesis
8. Scientists discover that metastases share a similar genetic profile to their primary tumour
9. Drug addiction, learning share common brain protein
10. Monkey talk, human speech share left-brain processing
11. Lions share of the best of Asias progressive minds in science and medicine convene

Post Your Comments:
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ... beliefs about the condition and the best ways to treat ...
(Date:12/10/2014)... 2014 CIE San Diego has launched an ... connective tissue that enhances care coordination among social service ... client-level information; earned a second $1 million grant from ... seniors aging in community and; will be recognized as ... th 4-6p. CIE San Diego today ...
(Date:12/4/2014)... BEACH GARDENS, Fla. , Dec. 3, 2014 ... management solutions, today announced that its DigitalPersona ® ... 4500 fingerprint readers have been deployed throughout First ... , South Carolina ... headquartered in Southern Pines, North Carolina ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
(Date:12/17/2014)... (PRWEB) December 17, 2014 Ipsen ... IPN; ADR: IPSEY), today announced that ... to as Somatuline®) was approved by the U.S. ... of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients ... or metastatic disease to improve progression-free survival (PFS). ...
(Date:12/17/2014)... 17, 2014 This report is ... Tubing industry. For an overview analysis, the report ... industry chain structure, industry overview, policy analysis, and ... industry has witnessed rapid development with key ... acquisitions. This report mentions quartz tubing upstream raw ...
(Date:12/17/2014)... Menlo Park, CA (PRWEB) December 17, 2014 ... Inc. announces today that it has entered into ... Daniels Midland Company (ADM) to apply DNA2.0’s proprietary ... industrial enzyme engineering process. , “We are extremely ... our ProteinGPS engineering platform. This proprietary bioengineering ...
(Date:12/17/2014)... 16, 2014  Vermillion, Inc. (NASDAQ: VRML ... today announced the next step in its expanded strategy ... provider with the naming of current Chief Operating Officer, ... Officer, while current Chairman of the Board and CEO ... Chairman. These changes are effective January 1, 2015. ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 82020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4
Cached News: